LIPO-Liposome Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome

LIPO 0.350

-4.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 613 who wrote (851)	9/21/1999 10:12:00 PM
From: Donald Gravenor	Read Replies (1) of 900

I know both the physicians mentionned in a previous posting. Dr. Johnson (from Vanderbilt in Nashville) is one of America's premier oncologists, and has not only prescribed adriamycin, but has received it, and even says that it has given him a resting tachycardia. If he, as a representative of the FDA says the drug shouldn't be released, I think we can basically count Evacet out on a permanent basis. I have very serious reservations about the pros[pects of a company which derives its income from (incidentllly extremely expensive form of) liposomal amphotericin. Finally, why is $5 a buying point ? Is there a strong technical support level there ? (I don't know anything about technical analysis). The fundamentals of the company seem pretty weak, from my perspective, at least right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next